Special Issue on ‘‘Biomarkers for Diseases”

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the winter of 2015)on the topic of‘‘Biomarkers for Diseases’’.As an emerging index,disease biomarkers have demonstrated the potential application in diagnosis and prognosis.The detection of the disease indicators at molecular level,DNA,RNA,protein or metabolites,could gain highly sensitive and specific signals that truly reflect     

Special Issue on ‘‘Big Data and Precision Medicine'

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the spring of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the     

Special Issue on ‘‘Big Data and Precision Medicine”

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the spring of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the     

Special Issue on ‘‘Big Data and Precision Medicine'

正The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the fall of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the collection of large amount of data from the population as well as patients of specific diseases.     

Special Issue on ‘‘Biomarkers for Human Diseases and Translational Medicine'

<正>The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.     

Special Issue on ‘‘Biomarkers for Human Diseases and Translational Medicine”

正The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.     

Special Issue on ‘‘Biomarkers for Human Diseases and Translational Medicine'

正The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.Diagnosis upon biomarkers would aid in early and more efficient intervention,while prognostic     

Special Issue on“Biomarkers for Diseases”

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the winter of 2015)on the topic of‘‘Biomarkers for Diseases’’.As an emerging index,disease biomarkers have demonstrated the potential application in diagnosis and prognosis.The detection of the disease indicators at molecular level,DNA,     

Special Issue on “Big Data and Precision Medicine”

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the spring of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the     

Special Issue on “Biomarkers for Autoimmune Diseases”

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the summer of 2015)on the topic of‘‘Biomarkers for Autoimmune Diseases’’.Autoimmune diseases(AIDs)are the third most common category of disease after cancer and heart disease and affect more than 5%of the general population.AIDs result     

蕲州地区的蕲艾、青蒿、黄花蒿与茵陈的考订

<正> 蕲州是我国中药材主要产地之一,是湖北省蕲春县的一个集镇,,是我国中医药大师李时珍的家乡。该地区生长的菊科蒿属植物Artemisia Linn。颇多,其中入药的有十余种,并在李时珍《本草纲目》中曾有记载。这里仅对该地区常见入药的蕲艾、青蒿、黄花蒿与茵陈结合《本草纲目》记载的材料作初步的考订。     

Chinchilla "big" and "little" gastrins

Gastrin heptadecapeptides (gastrins I and II which differ in the presence of sulfate on the tyrosine of the latter) have been purified and sequenced from several mammalian species including pig, dog, cat, sheep, cow, human and rat. A 34 amino acid precursor ("big" gastrin), generally accounting for only 5% of total gastrin immunoreactivity, has been purified and sequenced only from the pig, human, dog and goat. Recently we have demonstrated that guinea pig (GP) "little" gastrin is a hexadecapeptide due to a deletion of a glutamic acid in the region 6-9 from its NH2-terminus and that GP "big" gastrin is a 33 amino acid peptide. The chinchilla, like the GP, is a New World hystricomorph. This report describes the extraction and purification of "little" and "big" gastrins from 31 chinchilla antra. Chinchilla "little" gastrin is a hexadecapeptide with a sequence identical to that of the GP and its "big" gastrin is a 33 amino acid peptide with the following sequence: (See text)